Delivery Order SPE2DB25D3404-SPE2DB25FUPSW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on June 17, 2025, with an ultimate completion date of June 18, 2025. The contract, valued at $10,763.35 under firm fixed pricing, calls for the delivery of Descovy 200-25 mg tablets in quantities of 30 units. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitive award, valued at $10,669.37 with firm fixed pricing, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 24, 2025. No...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,184.02 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,095.55 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 22, 2025. The award was issued on September 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $20,176.14 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal procurement....
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $2,964.98 and ultimate completion date of June 2, 2025. This is a non-set-aside competitive award fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract, valued at $3,835.11 under a firm fixed-price arrangement, covers the delivery of Descovy 200-25 mg tablets in quantities of 30 units. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $10,027.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. The contract, with an ultimate completion date of August 8, 2025, represents a pharmaceutical delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $84,036.28 and is set to conclude on August 12, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPSWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a ceiling value of $8,518.60 and an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, holds an extensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX) that runs through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The Descovy delivery order reflects the company's established role as a key pharmaceutical supplier within the DLA's medical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 8/11/25 |